These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Risk assessment policy in the United States. Flamm WG Prog Clin Biol Res; 1986; 208():141-9. PubMed ID: 3960883 [No Abstract] [Full Text] [Related]
43. US broadens scientific base of controls on carcinogens. Reichhardt T Nature; 1996 Apr; 380(6576):659. PubMed ID: 8614448 [No Abstract] [Full Text] [Related]
44. US firms slam EU over risk. J Environ Monit; 1999 Dec; 1(6):111N. PubMed ID: 11529180 [No Abstract] [Full Text] [Related]
45. The BEIR III controversy. Fabrikant JI Radiat Res; 1980 Dec; 84(3):361-8. PubMed ID: 6893865 [No Abstract] [Full Text] [Related]
46. Waiting for a philosopher king: making cancer policy until certainty arrives. Speth G Tex Rep Biol Med; 1978; 37():95-106. PubMed ID: 752987 [No Abstract] [Full Text] [Related]
47. Confidentiality policy for HIV-related information: an analytical framework for sorting out hard and easy cases. Turkington RC Villanova Law Rev; 1989 Sep; 34(5):871-908. PubMed ID: 11651164 [No Abstract] [Full Text] [Related]
52. The cost of AZT. Thomas EH; Fox DM AIDS Public Policy J; 1987; 2(2):17-21. PubMed ID: 11650027 [No Abstract] [Full Text] [Related]
53. Pressure grows on phthalates. J Environ Monit; 1999 Jun; 1(3):42N. PubMed ID: 11529117 [No Abstract] [Full Text] [Related]
54. Institutional review of medical research. Cost-benefit analysis, risk-benefit analysis, and "the possible effects of research on public policy". Schwartz RL J Leg Med; 1983 Jun; 4(2):143-66. PubMed ID: 6411846 [No Abstract] [Full Text] [Related]
55. Human cloning: should the United States legislate against it? Yes: individual dignity demands nothing less ; No: the potential for good is too compelling. Annas GJ; Robertson JA ABA J; 1997 May; 83():80-1. PubMed ID: 11656683 [No Abstract] [Full Text] [Related]
56. Human Exposure: the key to better risk assessment. Wakefield J Environ Health Perspect; 2000 Dec; 108(12):A559-65. PubMed ID: 11133418 [No Abstract] [Full Text] [Related]
57. Needle exchange programs: ethical and policy issues. O'Brien M AIDS Public Policy J; 1989; 4(2):75-82. PubMed ID: 11651961 [No Abstract] [Full Text] [Related]
58. DNA identification systems: social policy and civil liberties concerns. Bereano PL J Int Bioethique; 1990 Sep; 1(3):146-55. PubMed ID: 11651004 [No Abstract] [Full Text] [Related]
59. Science and regulation. New science for chemicals policy. Schwarzman MR; Wilson MP Science; 2009 Nov; 326(5956):1065-6. PubMed ID: 19965413 [No Abstract] [Full Text] [Related]
60. Impact of public policy on the development of drugs for pregnant women and children. Mirkin BL Clin Res; 1975 Oct; 23(4):233-7. PubMed ID: 10237297 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]